What HGH fragment 176-191 is, why protocols are structured the way they are, and the daily/weekly metrics that actually reveal whether it works for you.
At a glance
Best for
HGH fragment 176-191 is a short segment of the human growth hormone molecule that retains the lipolytic (fat-mobilising) properties of full HGH but, in research, does not appear to share its anabolic or glycemic effects. Whether that holds outside the lab is a separate question. The tracking problem is straightforward.
Stimulate lipolysis — the mobilisation of stored fat for use as energy — without raising IGF-1 or affecting insulin sensitivity. In animal models the effect is well-documented. Human data is much thinner.
The "fasted morning" timing is specific — the rationale is that fat oxidation is maximised when insulin is low, so a peptide that pushes lipolysis pairs with a low-insulin window.
The IGF-1 point is important: if you see IGF-1 rise meaningfully on a fragment cycle, you're either getting impure material or the marketing claim is wrong for you.
If you're already lean (~12% body fat for men, ~20% for women) the protocol's signal is small and easily lost in noise.
If you carry more body fat, the cleanest expected pattern at 8 weeks:
Anything dramatic is more likely diet, water, or training adaptation — and the log proves it.
At week 8 you'll either see a downtrend that survives normal noise, or you won't. Either way you have data, not vibes.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.